ECMC Network
@ECMC_UK
Experimental Cancer Medicine Centres develop new cancer therapies. Jointly funded @CR_UK @LPTrustUK @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust
ID:1903979808
http://www.ecmcnetwork.org.uk/ 25-09-2013 12:11:12
6,5K Tweets
3,2K Followers
1,9K Following
Great to see the report from Teenage Cancer Trust on the issues facing teenagers & young adults accessing trials & the importance of trial awareness through the ECMC TrialFinder tool.
Join today's webinar at 3pm on considering this community in trials: events.teams.microsoft.com/event/267e84be… #TYACAM
Hear from Juanita (The ICR/The Royal Marsden NHS Foundation Trust ECMC) at the Science and Innovation at Cancer Research UK's upcoming #CRUKBrain24 in September⬇️
Congratulations to Birmingham paediatric ECMC's Pam Kearns on winning Children’s Cancer and Leukaemia Group's Lifetime Achievement Award! Pam has made a huge contribution to the field through her leadership & dedication to children's & young people's cancers. We're proud to have her as part of the network.
This vital biobanking resource for researchers is helping to advance their knowledge of children’s & young people’s cancers. Deborah Tweddle at Sir Bobby Robson Cancer Trials Research Centre is the Director of VIVO Biobank and is dedicated to advancing the way these cancers are treated. 👇 #TYACAM
So happy to finally share! Amazing project and amazing team behind this! Here's to the next steps - translating it into the clinic to really help patients get a quicker diagnosis. World CUP Awareness CUP Foundation CRUK National Biomarker Centre Natalie Cook 💙 NIHR Manchester Biomedical Research Centre nature.com/articles/s4146…
🗣️Call 4 new members of the ECMC Network Research Nurse steering committee. Great opportunity 2 help shape Research Nurse education and research across the adult and paediatric ECMCs. 4 further details rb.gy/6fxnk9 or DM 🙂
Did you hear? We're hosting a webinar on teenager & young adult #Cancer , sharing experience & expertise to overcome the unique challenges facing this age group, including access to #ClinicalTrials & trial design.
📅 30 April
⏰ 3 – 4pm
Sign up: events.teams.microsoft.com/event/267e84be… #TYACAM
Join Dan Stark (Leeds ECMC) & Gillian Horne (Glasgow ECMC) for a webinar dedicated to teenager & young adult cancer on 30 April @ 3pm.
Hear about exemplary projects addressing the challenges facing this age group & from a patient's perspective👉events.teams.microsoft.com/event/267e84be… #TYACAM
New frontiers in exploiting stroma for therapy. FAP directed precision medicine. Phase I of AVA600 showing tolerability, plasmas/tumour PK and clinical proof of concept response in FAP high tumours. Abstract CT188 #AACR2024 The ICR The Royal Marsden NHS Foundation Trust ECMC Network
In a session on novel agents & emerging therapeutic strategies at #AACR24 , Jonathan Yang (Memorial Sloan Kettering Cancer Center) presents data on the safety & efficacy of AZD1390 + radiation therapy for #Glioblastoma , co-authored by Anthony Chalmers 💙 (@UofGlasgow): bit.ly/3Pxjony
UofG MVLS
Head over to the clinical trials poster session at #AACR24 to hear Markus Muller (Boehringer Ingelheim) presenting data a PII trial of DLL3-targeting T-cell engager in relapsed #SCLC / neuroendocrine carcinomas, co-authored by Alastair Greystoke (@Newcastle_ECMC) 👉 bit.ly/3TLpALj
Hear from udaibanerji (@ICR_London/The Royal Marsden NHS Foundation Trust ECMC co-lead) in the poster session at #AACR24 now, presenting data from the study of acoustic cluster therapy with chemotherapy & insonation in colorectal cancer patients. Head over to section 36. 👉 bit.ly/4cuu8wM
Hear from Alison Dickson (University of St Andrews) presenting data at #AACR24 on factors in the #TME that contribute to tumorigenesis + therapeutic response. Check out poster #6222/25, co-authored by Ruth, Sarah Blagden, Stefan Symeonides & Natalie Cook 💙: bit.ly/3TWW0Tn
.The ICR & The Royal Marsden NHS Foundation Trust ECMC co-lead udaibanerji is presenting a poster, co-authored by Ruth, Natalie Cook 💙 & Jeff Evans on PI trial investigating FAP-released & TME-targeting doxorubicin peptide drug conjugate in FAP-positive #SolidTumors : bit.ly/495xIL4
Messing with (cancer cell) stress. PK-PD and toxicity of the dose escalation cohort of NXP800 (NCT05226507) Abst CT111 at #AACR2024 . Target engagement confirmed, next steps to evaluate efficacy in ARID1A mutated tumours. The ICR The Royal Melbourne Hospital ECMC Network NIHR Royal Marsden BRC with @ICRLondon and CRF